The Laboratory of Tumour Immunology at the St. Anna Childrens Cancer Research Institute (CCRI) (www.ccri.at), Vienna, Austria, is accepting applications for the position of a postdoc/staff scientist in the area of:
Tumour Immunology and Tumour Immune Therapy
focussing on molecular and genetic aspects of immune regulation by dendritic cells.
The CCRI is a multi-disciplinary research institute focusing on various aspects of cancer development, diagnosis, and treatment. The Laboratory of Tumour Immunology has been engaged in the study of the cellular and molecular biology of anti-tumour immunity for many years. In line with the CCRIs strong translational research focus, the Laboratory of Tumour Immunology developed a technology platform for anti-tumour immune therapy, which is now studied in clinical phase II trials. Our basic research projects aim at an understanding of the molecular biology and genetics of immune regulation by dendritic cells with particular emphasis on negative regulatory feedback loops, and exploiting this knowledge for cancer immune therapy.
A sorrow understanding of cellular and molecular tumour immunology is expected; knowledge of the biology of dendritic cells is preferred. An interest in translational research bringing biological concepts to clinical application is essential for this position. We are looking for scientists experienced in technologies related to human immunology such as flow cytometry, immune histochemistry, cell culture, or assay systems for the investigation of immune functions, etc.
Applications shall be submitted to Thomas Felzmann by e-mail (thomas.felzmann[ at ]ccri.at)
Tumour Immunology and Tumour Immune Therapy
focussing on molecular and genetic aspects of immune regulation by dendritic cells.
The CCRI is a multi-disciplinary research institute focusing on various aspects of cancer development, diagnosis, and treatment. The Laboratory of Tumour Immunology has been engaged in the study of the cellular and molecular biology of anti-tumour immunity for many years. In line with the CCRIs strong translational research focus, the Laboratory of Tumour Immunology developed a technology platform for anti-tumour immune therapy, which is now studied in clinical phase II trials. Our basic research projects aim at an understanding of the molecular biology and genetics of immune regulation by dendritic cells with particular emphasis on negative regulatory feedback loops, and exploiting this knowledge for cancer immune therapy.
A sorrow understanding of cellular and molecular tumour immunology is expected; knowledge of the biology of dendritic cells is preferred. An interest in translational research bringing biological concepts to clinical application is essential for this position. We are looking for scientists experienced in technologies related to human immunology such as flow cytometry, immune histochemistry, cell culture, or assay systems for the investigation of immune functions, etc.
Applications shall be submitted to Thomas Felzmann by e-mail (thomas.felzmann[ at ]ccri.at)
Comments